Complement activation by beta-amyloid in Alzheimer disease.
Alzheimer disease (AD) is characterized by excessive deposition of the beta-amyloid peptide (beta-AP) in the central nervous system. Although several lines of evidence suggest that beta-AP is neurotoxic, a mechanism for beta-AP toxicity in AD brain remains unclear. In this paper we provide both dire...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
1992
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC50268/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1438191/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.89.21.10016 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
